Sort
141,003 grants matching “cytokine”
A network model of the gut host-microbe ecosystem in Inflammatory Bowel Disease
$636,092Dan R Littman · New York University School Of Medicine · R01 · FY2017 · DK
A network model of the gut host-microbe ecosystem in Inflammatory Bowel Disease
$636,092Dan R Littman · New York University School Of Medicine · R01 · FY2016 · DK
A network model of the gut host-microbe ecosystem in Inflammatory Bowel Disease
$636,092Dan R Littman · New York University School Of Medicine · R01 · FY2018 · DK
A novel CD4+ T cell helper population in Lupus Nephritis
$636,069Maria Virginia Pascual · Weill Medical Coll Of Cornell Univ · U19 · FY2023 · AI
MOLECULAR MECHANISMS OF CHRONIC AIRWAY AND ALVEOLAR DISEASE IN HIV
$636,058Jeffrey J Atkinson · Washington University · U01 · FY2014 · HL
LncRNA SNHG12, vascular senescence, and atherosclerosis
$636,055Mark W Feinberg · Brigham And Women'S Hospital · R01 · FY2021 · HL
Health outcomes and cognitive effects of marijuana use among persons living with HIV/AIDS
$636,033Robert L Cook · University Of Florida · R01 · FY2020 · DA
Drug delivery by carrier erythrocytes
$636,016Vladimir R Muzykantov · University Of Pennsylvania · R01 · FY2017 · HL
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Target Aberrant Venous Development
$636,000Elisa Boscolo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · HL
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Target Aberrant Venous Development
$636,000Elisa Boscolo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HL
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Target Aberrant Venous Development
$636,000Elisa Boscolo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · HL
Venous Malformations (VM): A Murine Mdoel to Identify Therapies to Target Aberrant Venous Development
$636,000Elisa Boscolo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · HL
Mechanisms underlying recurrent bacterial vaginosis and HIV risk A Multidisciplinary approach
$635,997Maria Luisa Alcaide · University Of Miami School Of Medicine · R01 · FY2023 · AI
Optimizing Immunity and Maternal Host Defense Against Congenital Cytomegalovirus Infection
$635,993Mark R. Schleiss · University Of Minnesota · R01 · FY2021 · HD
Host Response to TB and AIDS
$635,945New York University School Of Medicine · R01 · FY2002 · HL
Thromboregulatory strategies to prolong xenograft survival.
$635,913Simon C Robson · Beth Israel Deaconess Medical Center · U01 · FY2008 · AI
Allergen-induced extracellular DNA in type 2 immunity
$635,887Hirohito Kita · Mayo Clinic Arizona · R01 · FY2023 · AI
CEBPD-Mediated Mechanisms of Glucocorticoid Insensitivity in Severe Asthma
$635,877Blanca E Himes · University Of Pennsylvania · R01 · FY2020 · HL
Biomarker signatures of biological, chemical, or psychological stress
$635,858David A Lawrence · Wadsworth Center · U01 · FY2009 · ES
New way in delivering immunomodulatory drugs in T1D
$635,857Reza Abdi · Brigham And Women'S Hospital · R01 · FY2022 · AI
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer
$635,854Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Trained immunity and the regulation of anti-fungal defense
$635,850Amariliz Rivera · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
The Metabolic Impact of Congenital Heterozygous ApoC-III Deficiency in Humans
$635,842Toni I. Pollin · University Of Maryland Baltimore · R01 · FY2011 · HL
Synthesis and Evaluation of Carbohydrate Vaccine Adjuvants
$635,738Hien M Nguyen · Wayne State University · R01 · FY2023 · AI
Synthesis and Evaluation of Carbohydrate Vaccine Adjuvants
$635,738Hien M Nguyen · Wayne State University · R01 · FY2024 · AI